Biosimilars 2019 is a phenomenal event which will be bringing together people from different domains of pharmaceutical and biopharmaceutical world such as researchers, analysts, regulatory and IPR Attorneys, Business Development Teams, Professors, PhD research scholars and more to discuss on the topics related to Biosimilars and Biologics. This international event also includes Keynote talks, Plenary sessions, Exhibitions, Poster Presentations, Workshop.

Biosimilars 2019 aims at providing opportunities to all its Speakers and Delegates to come together to interact and exchange new ideas related to biosimilars and biologics. This International conference will incorporate world renowned keynote speakers, plenary speeches, young research forum, poster presentations, technical workshops and career guidance sessions.

The Global biosimilars market is expected to reach USD Billion by 2023 from USD Billion in 2017, at a CAGR of By far European Countries dominate the market owing to the favorable government regulations in this region representing 80% of global spending followed by USA which approximately covers around 50% global biologics market and coming to Asia it is expected that in the next 5 years global pharmaceutical spending will rise upto 43% from a roughly 38%.

References:  

•  MARKETSandMARKETS: 
•  Grand View Research :